American Vanguard Corporation v. United States

CourtUnited States Court of Federal Claims
DecidedMarch 22, 2019
Docket16-694
StatusUnpublished

This text of American Vanguard Corporation v. United States (American Vanguard Corporation v. United States) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Vanguard Corporation v. United States, (uscfc 2019).

Opinion

United States Court of Federal Claims No. 16-694 C Filed Under Seal: January 28, 2019 Reissued: March 22, 2019 ___________________________________

AMERICAN VANGUARD CORPORATION,

Plaintiff,

v.

UNITED STATES OF AMERICA,

Defendant. ____________________________________

Barry M. Hartman, Kirkpatrick & Lockhart, Washington, D.C., for plaintiff.

Tara K. Hogan, United States Department of Justice, Washington, D.C., for defendant.

ORDER AND OPINION

Hodges, Senior Judge.

Plaintiff American Vanguard Corporation filed this claim, alleging that a Stop Sale, Use, or Removal Order issued by the Environmental Protection Agency constituted an unconstitutional taking of its property. The alleged property is American’s pentachloronitrobenzene (PCNB) business, including personal and intangible property used for manufacturing, selling, and/or distributing PCNB and PCNB-related products.

Defendant filed a motion for summary judgment maintaining inter alia that plaintiff is not entitled to compensation for economic losses suffered as a result of congressionally authorized enforcement actions taken by the EPA. Plaintiff filed a partial motion for summary judgment in opposition, contending essentially that it had a cognizable Fifth Amendment property interest, and that the said property was “taken.”

For the reasons stated below, we find that plaintiff does not possess a cognizable property interest in the property allegedly taken. Plaintiff’s complaint must be dismissed. BACKGROUND

Congress maintains a comprehensive legislative scheme regarding the regulation of pesticides and the EPA’s approval of pesticide registrations. The Federal Insecticide, Fungicide, and Rodenticide Act provides that the EPA’s approval of registrations is conditioned on a determination that a pesticide, including its use directions and composition, “will not generally cause unreasonable adverse effects on the environment.” 7 U.S.C. § 136a(c)(5)(D). The Act defines “unreasonable adverse effects” as “any unreasonable risk to man or the environment, taking into account the economic, social, and environmental costs and benefits of the use of any pesticide.” 7 U.S.C. § 136(bb).

Registration requires an applicant to disclose the “complete formula of the pesticide,” including data related to certain impurities of toxicological significance, by submitting a form called a Confidential Statement Formula, or CSF. 1 7 U.S.C. § 136a(c)(1)(D); 40 C.F.R. § 152.50(f). The form instructs the applicant to list impurities greater than or equal to 0.1% or impurities of lesser amount determined by the EPA to be of toxicological significance and to propose certified limits. 40 C.F.R. § 158.320(c), (d). Selling or distributing registered pesticide the composition of which differs at the time of its sale or distribution from its CSF description is unlawful. 7 U.S.C. § 136j(a)(1)(C).

The Act generally prohibits the sale or distribution of a pesticide product unless it is registered. 7 U.S.C. § 136a(a). To ensure compliance, the EPA may issue a “stop sale, use, or removal order” where “there is reason to believe that on the basis of inspections or tests” that a pesticide is in violation of the Act or has been or is intended to be distributed or sold in violation of its provisions. 7 U.S.C. § 136k(a). Such orders are to be issued only where the EPA has reason to believe that there is a potential hazard to human health or the environment or to address serious violations that present a threat of harm.

American manufactures, distributes, and sells a variety of agricultural and non- agricultural pesticide products, such as herbicides, insecticides, and fungicides, domestically and internationally. One of its product lines is based on an active ingredient known as PCNB, which has been registered with the EPA since 1985. PCNB is a fungicide that may be formulated into end-use products for terrestrial food crop and non- crop applications. American contends that these products prevent mold fungus growth on grass and are applied on various crops. It adds that effective application of the product must occur in October and November and that it is busiest in September and October.

1 An “[i]mpurity associated with an active ingredient means: (1) Any impurity present in the technical grade of active ingredient; and (2) Any impurity which forms in the pesticide product through reactions between the active ingredient and any other component of the product or packaging of the product.” 40 C.F.R. § 158.300. -2- American detected an impurity in its PCNB products in 1993 and informed the EPA. (ECF No. 49 at 16 (*************************************************).) EPA assigned the report internally for non-expedited review, but took no further action. Pursuant to section 136a–1 of the Act, which required the EPA to review older pesticides for compliance with current regulatory standards, the EPA completed its review of PCNB to determine whether the PCNB should be reregistered in 2006. EPA concluded that for most uses of PCNB, the adverse environmental effects outweighed the benefits of the uses. As a result, EPA found that PCNB was ineligible for reregistration; it did not initiate proceedings to cancel registrations, however. 2

EPA in 2009 learned that Australian researchers and the Australian authority in charge of regulating pesticides revealed the presence of dioxins in PCNB products. EPA then requested that American provide samples of PCNB for analysis. The result of the analysis completed in January 2010 showed the presence of dioxin in the samples. EPA officials then met with plaintiff to discuss elimination of the PCNB impurities. 3 EPA’s Office of Pesticide Programs referred the matter to the Office of Enforcement & Compliance in the summer of 2010 to determine if enforcement action was appropriate.

The Office of Enforcement & Compliance found that, based on the sample testing results, that adequate evidence that the PCNB products sold by plaintiff contained dioxin, an impurity of toxicological significance that was not identified on the CSF. During the review, they briefed the EPA’s Director of the Waste and Chemical Enforcement Division (Ms. Kelley) and the Assistant Administrator for Enforcement’s aide (Mr. Kushner). EPA issued a Stop Sale, Use, or Removal Order on August 2010, signed on behalf of Ms. Kelley by Mr. Lott, her deputy.

EPA’s Order explained that a registrant may not sell or distribute a pesticide product with a composition that differs from the approved composition. It found that the CSF submitted by American had not identified the impurity and therefore had not reported adequately the composition of the product as required by 7 U.S.C. § 3 and 40 C.F.R. § 158.320.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Willow River Power Co.
324 U.S. 499 (Supreme Court, 1945)
Regional Rail Reorganization Act Cases
419 U.S. 102 (Supreme Court, 1974)
Penn Central Transportation Co. v. New York City
438 U.S. 104 (Supreme Court, 1978)
Ruckelshaus v. Monsanto Co.
467 U.S. 986 (Supreme Court, 1984)
Phillips v. Washington Legal Foundation
524 U.S. 156 (Supreme Court, 1998)
Brown v. Legal Foundation of Washington
538 U.S. 216 (Supreme Court, 2003)
Acceptance Ins. Companies, Inc. v. United States
583 F.3d 849 (Federal Circuit, 2009)
Huntleigh USA Corporation v. United States
525 F.3d 1370 (Federal Circuit, 2008)
Bair v. United States
515 F.3d 1323 (Federal Circuit, 2008)
Mingus Constructors, Inc. v. The United States
812 F.2d 1387 (Federal Circuit, 1987)
Hearts Bluff Game Ranch, Inc. v. United States
669 F.3d 1326 (Federal Circuit, 2012)
Mitchell Arms, Inc. v. United States
7 F.3d 212 (Federal Circuit, 1993)
Tabb Lakes, Ltd. v. United States
10 F.3d 796 (Federal Circuit, 1993)
American Vanguard Corporation v. Jackson
803 F. Supp. 2d 8 (District of Columbia, 2011)
SkyHawke Technologies, LLC v. Deca International Corp.
828 F.3d 1373 (Federal Circuit, 2016)
Sharpe v. United States
134 Fed. Cl. 805 (Federal Claims, 2017)
Del-Rio Drilling Programs Inc. v. United States
146 F.3d 1358 (Federal Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
American Vanguard Corporation v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-vanguard-corporation-v-united-states-uscfc-2019.